| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071770A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071766A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
| 01/31/2001 | EP1071762A1 Control of gene expression |
| 01/31/2001 | EP1071761A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 01/31/2001 | EP1071754A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071747A2 Immortalised cell lines derived from normal human skin tissues |
| 01/31/2001 | EP1071746A2 Process for preparing doxorubicin |
| 01/31/2001 | EP1071745A2 Process for synthesizing cox-2 inhibitors |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
| 01/31/2001 | EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/31/2001 | EP1071697A1 Regulated target expression for screening |
| 01/31/2001 | EP1071696A1 Programmed cell death and caspase-12 |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071434A1 Cnre binding factors and uses thereof |
| 01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
| 01/31/2001 | EP0593428B1 Myconematicide |
| 01/31/2001 | CN1282371A Ac (DNA encoding C6 beta-chemokine leukotactin-1 (Lkn-1) isolated from human |
| 01/31/2001 | CN1282369A Polypeptides having aminopepyidase activity and nucleic acids encoding same |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/31/2001 | CN1282251A Method and material for treating and preventing mucosal tissue inflammation |
| 01/31/2001 | CN1281894A Method for transferring human endostatin gene lactic bacteria, its product and application |
| 01/31/2001 | CN1281893A Truncated type human insulin-like growth factor-I double gene copy engineering strain and its construction method |
| 01/31/2001 | CN1281892A Method for producing photosynthetic bacterial thallus by using molasses alcohol mash liquor |
| 01/31/2001 | CN1281865A Microbial polysaccharide, its preparation method and medicine composite containing it |
| 01/31/2001 | CN1281700A Sulfur bacterium preparation for regulating gastointestinal function and production method thereof |
| 01/31/2001 | CN1061377C Monobleb viras carrier capable of being used in packaging recombination of adenovirus concomitant virus and use thereof |
| 01/31/2001 | CN1061374C Synthetic DNA series of coded sweet protein and production method thereof |
| 01/30/2001 | US6180850 Ku70 is the noncatalytic subunit of dna-protein kinase, encoded by specified polynucleotides; transgenic plants; modulating the level of ku70 in a plant; modulating nucleic acid expression in plants |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180775 Bacillus thuringiensis isolates active against weevils |
| 01/30/2001 | US6180612 Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives |
| 01/30/2001 | US6180407 Cloning and/or sequencing vector |
| 01/30/2001 | US6180396 Anaerobic fermentator for generating methane and carbon dioxide, a separator, a means for forming hydrogen from methane, a means for fixing carbon dioxide by reducing with hydrogen under presence of catalyst; pollution control |
| 01/30/2001 | US6180392 Streptomyces strains and process to produce single streptogramin component |
| 01/30/2001 | US6180391 Vector for cloning preferential heterologous nucleotide sequences |
| 01/30/2001 | US6180388 Process for the enzymatic hydrolysis of polyamide 6.6 to give adipic acid monomers and hexamethylenediamine monomers |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
| 01/30/2001 | US6180382 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 01/30/2001 | US6180381 Pseudomonas chlororaphis microorganism, polyurethane degrading enzyme obtained therefrom, and method of use |
| 01/30/2001 | US6180376 Extraction of triglycerides from microorganisms |
| 01/30/2001 | US6180373 Eschericha and cornyebacteria which are genetically engineered to produce amplified concentratons of preferential amino acids |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
| 01/30/2001 | US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient |
| 01/30/2001 | US6180361 Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase |
| 01/30/2001 | US6180360 Process of producing β-lactam antibiotics applying micro-organisms with increased ligase activity |
| 01/30/2001 | US6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase |
| 01/30/2001 | US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity |
| 01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180016 Mixture of apatite in binder |
| 01/30/2001 | US6179926 Process for steeping corn and steepwater having a low reducing sugar content made therefrom |
| 01/30/2001 | CA2268641C Method of gasifying or degasifying a liquid |
| 01/30/2001 | CA2179423C Hydrophobic bioremediants |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001006006A1 Environmental stress resistance gene |
| 01/25/2001 | WO2001005997A2 Method for production of tetanus toxin using media substantially free of animal products |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005979A1 Process for producing target substance by fermentation method |
| 01/25/2001 | WO2001005976A1 Mutated ribosomal protein l3 |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005961A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 01/25/2001 | WO2001005960A1 Process for producing l-amino acid |
| 01/25/2001 | WO2001005959A1 Process for producing target substance by fermentation method |
| 01/25/2001 | WO2001005950A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005941A2 Storage of microorganisms, cells and tissue |
| 01/25/2001 | WO2001005939A1 Process for producing target substance by fermentation |
| 01/25/2001 | WO2001005938A1 A method for producing mycelia of ganoderma lucidum containing selenium and other trace elements |
| 01/25/2001 | WO2001005927A1 Surfactants and detergents and washing method on the basis of microorganism/enzyme complex liquid culture medium |
| 01/25/2001 | WO2001005836A1 Polypeptidic compositions and methods for the treatment of tumors |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005833A1 Odorant receptors |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005828A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | WO2001005801A1 Novel nucleic acid base pair |
| 01/25/2001 | WO2000073413A3 Apparatus and method for cell disruption |
| 01/25/2001 | WO2000071566A3 Novel organic anion transport proteins |